DQP-26 | Interleukin Related interleukin-related.com

Product Name :
DQP-26

Search keywords :
DQP-26

drugId :
null

Target Vo:
Glutamate receptor ionotropic, NMDA 2C

Target Vo Short Name :
GRIN2C

Moa_Name:
Glutamate receptor ionotropic, NMDA 2C modulators

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Emory University

Active Company_Name :
Emory University

Active Indication_Name:
Nervous System Diseases

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
PDCD4 Rabbit mAb manufacturer
TBK1 Mouse mAb medchemexpress
NEDD8 Antibody: NEDD8 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 9 kDa, targeting to NEDD8. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Rat.

Author: Interleukin Related

Related Posts